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Abstract
Background: Traditional Chinese Medicine (TCM), a complementary and alternative medical system in
Western countries, has been used to treat various diseases over thousands of years in East Asian
countries. In recent years, many herbal medicines were found to exhibit a variety of effects through
regulating a wide range of gene expressions or protein activities. As available TCM data continue to
accumulate rapidly, an urgent need for exploring these resources systematically is imperative, so as to
effectively utilize the large volume of literature.
Methods: TCM, gene, disease, biological pathway and protein-protein interaction information were
collected from public databases. For association discovery, the TCM names, gene names, disease names,
TCM ingredients and effects were used to annotate the literature corpus obtained from PubMed. The
concept to mine entity associations was based on hypothesis testing and collocation analysis. The
annotated corpus was processed with natural language processing tools and rule-based approaches were
applied to the sentences for extracting the relations between TCM effecters and effects.
Results: We developed a database, TCMGeneDIT, to provide association information about TCMs,
genes, diseases, TCM effects and TCM ingredients mined from vast amount of biomedical literature.
Integrated protein-protein interaction and biological pathways information are also available for exploring
the regulations of genes associated with TCM curative effects. In addition, the transitive relationships
among genes, TCMs and diseases could be inferred through the shared intermediates. Furthermore,
TCMGeneDIT is useful in understanding the possible therapeutic mechanisms of TCMs via gene
regulations and deducing synergistic or antagonistic contributions of the prescription components to the
overall therapeutic effects. The database is now available at http://tcm.lifescience.ntu.edu.tw/.
Conclusion: TCMGeneDIT is a unique database that offers diverse association information on TCMs.
This database integrates TCMs with biomedical studies that would facilitate clinical research and elucidate
the possible therapeutic mechanisms of TCMs and gene regulations.
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Background
Traditional Chinese Medicine (TCM), a complementary
and alternative medical system in Western countries, has
been used to treat various diseases over thousands of years
in East Asian countries. The fundamental principles of
TCM are based on the Yin-Yang doctrine, the symbolic
way of designating opposing forces, and the five element
theory that everything in the Universe is dominated and
balanced by the five elements, wood, fire, earth, metal and
water [1]. The therapeutic mechanism of TCM focuses on
enhancing human body's resistance to diseases by
improving the inter-connections among self-controlled
systems and integrating the human body with the envi-
ronment [2]. The practice of TCM involves physical ther-
apy such as acupuncture and chemical therapy using
materials originating from plants, minerals and animals,
while TCM natural products may comprise one or more
herbs in the form of decoctions [1,3]. In recent years,
many herbal medicines have been reported to be associ-
ated with various symptoms or diseases and may exhibit a
variety of effects through regulating a wide range of gene
expressions or protein activities, such as the anti-tumor
effects through the induction of the DR3 and DR4/5 death
receptors in human monocytic leukemia cells [4], the
anti-inflammatory potential through the inhibition of
cytokine, iNOS and COX-2 expression via the NF-kappaB
pathway [5], the hepatoprotective effect through the acti-
vation of pregnane X receptor in rats [6], the expression of
bcl-2 oncogene in gastric precancerous lesions [7], the up-
regulation of proapoptotic Bax expression in human blad-
der carcinoma T24 cells [8], the anti-aging effect on the
cerebral gene expression levels in the senescence-acceler-
ated mouse prone 8/Ta [9], and the alteration of gene
expressions of hepatic stellate cells against hepatic fibrosis
[10]. Therefore, studies about the connections between
the TCMs, genes and diseases are emerging and impor-
tant. In this study, TCM primarily means the natural prod-
ucts developed from plants and animals.
The primary goal of text mining is to retrieve knowledge
hidden in text and to present the distilled knowledge such
as associations, patterns to users in a concise form [11].
With the rapid increase of available TCM data, there is an
urgent need to explore these resources effectively from the
large quantity of literature [12]. Over the past few years,
several studies have been made on the mining or extrac-
tion of TCM information from literatures, such as under-
standing ZHENG (syndrome) in TCM in the context of
neuro-endocrine-immune network [13], extraction of
clinical TCM formula data from literature [14], finding
functional community of related genes using TCM knowl-
edge, symptom complex [15], and extracting knowledge
of drugs and formulae from semi-structured text [16].
Many databases were developed to provide researchers
with different aspects of TCM information, but few of
them are published, presented in English, and freely
accessible. For instance, TCM-ID contains information on
prescriptions, herbs, herbal ingredients and 3D structures
of partial herbal ingredients [17], the Chinese herbal med-
icines toxicology database holds herb monographs with a
full toxicity profile and grading plus scientific evidences
[18], the 3D structure database consists of chemical com-
pounds isolated from Chinese traditional herbs [19], and
the TCM database includes basic herb data, chemical com-
ponents, molecular structures, and bioactive data [20].
However, to date, there has been no attempt to develop a
database integrating information about TCMs, genes and
diseases using text mining. Furthermore, little attention
has been given to build a knowledge base containing asso-
ciations between TCMs and genes.
The purpose of this paper is to present a database, TCM-
GeneDIT, providing associations about TCMs, genes, dis-
eases, effects and ingredients, and relations between TCM
effects and effecters from vast amount of biomedical liter-
ature. Information about protein-protein interactions and
biological pathways from public databases is also accessi-
ble. We illustrated the value of TCMGeneDIT by its utility
in many aspects and two use cases about the possible ther-
apeutic mechanisms of TCMs and synergistic or antago-
nistic contribution of the prescription component. The
integrated genomics, proteomics, and text mining data,
and user-friendly web interfaces in TCMGeneDIT make it
a one-stop site for TCM and modern biomedical research-
ers. Thus, the database would facilitate clinical research
and offer a better understanding for researchers of the
TCM and gene regulation-involved therapeutic mecha-
nisms.
Methods
Data sources and contents
TCMGeneDIT, a relational database, is implemented by
MySQL, Perl and PHP programming languages in the
Linux environment. Figure 1 presents the simplified rela-
tional scheme of our database. Each TCM herb may con-
tain various ingredients and involve several biological
pathways through its interactions with numerous genes,
which could be supported by one or many literature evi-
dences; and these interactions may help in the discovery
of new therapies for diseases.
TCM herb data were collected and integrated from the
HULU TCM professional web site http://
www.hulu.com.tw/ and TCM-ID. As of now, our database
includes over 2,000 TCM entries. In addition, ingredient
data obtained from the Chinese medicine resource web
http://www.spec-g.com.tw/newherb/ serve as a supple-
mentary to the above-mentioned two sources. The general
human gene information, including official gene symbol,
aliases, descriptions and functions were retrieved fromBMC Complementary and Alternative Medicine 2008, 8:58 http://www.biomedcentral.com/1472-6882/8/58
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NCBI Entrez Gene [21]. The scope of the dictionary on
gene names was expanded by ProThesaurus-Wiki [22].
Disease names were extracted from the heading and entry
term fields in the disease (C) section of the medical sub-
ject headings vocabulary (MeSH), except subsection C22,
animal disease and C23, pathological conditions, signs
and symptoms. The entry terms could be regarded as the
synonyms of the disease names. Nonspecific MeSH terms
like 'disease', 'cancer' or 'neoplasm' were excluded. Cur-
rently, the database covers 13167 gene and 3360 disease
entries, respectively. 38,072 MEDLINE abstracts were col-
lected through PubMed with herbal medicine generic
names and specific epithets. The relationships between
genes and diseases were collected from PharmGKB [23].
The protein-protein interaction data, including interact-
ing partners, interaction types and detection methods,
were obtained from HPRD [24] and IntAct [25]. The bio-
logical pathway information describing pathway types,
regulations for genes, and/or experiments was retrieved
from HPRD, KEGG [26] and CGAP [27]. Most association
information and potential TCM effects were mined and
extracted from literature abstracts. Association visualiza-
tion was implemented using Graphviz, open source graph
visualization software http://www.graphviz.org/. Figure 2
shows our text mining approach and information integra-
tion for developing TCMGeneDIT.
Literature corpus annotation
The TCM names, gene names, MeSH disease terms, TCM
ingredients and effects were used to annotate the literature
The simplified relational scheme of TCMGeneDIT Figure 1
The simplified relational scheme of TCMGeneDIT. Each gray box represents an entity with various major attributes 
characterized by oval-shape. For instance, each TCM herb may be associated with one or many genes involving in several sign-
aling pathways and have many interacting partners. Theses associations may be related to the therapeutic mechanisms for cer-
tain diseases and could be supported by scientific evidences.
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The text mining approach and information integration for TCMGeneDIT Figure 2
The text mining approach and information integration for TCMGeneDIT. Literature corpus about TCMs was col-
lected from PubMed and used for entity annotations and information extraction. Annotated documents were mined based on 
hypothesis test and collocation analysis to discover entity associations. On the other hand, the raw corpus was pre-processed 
with public tools and several rules can be applied to the processed sentences for extracting the relations between effecters and 
effects. The constructed effect set was used to filter candidate relation and literature annotation. Protein-protein interactions 
and biological pathways were integrated into our database and disease candidate genes from PharmGKB were used for transi-
tive inference. Users can access the database via the web interface. Thick arrow indicates the basic work flow of TCMGen-
eDIT.
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corpus. All words were queried against documents in a
case-insensitive and exact string matching manner.
We used the generic names and specific epithets such as
Ganoderma lucidum of the TCM scientific names to match
text. In addition, the abbreviated forms, for example, G.
lucidum and G lucidum were considered.
After initial gene name identification, the most recent 100
gene-annotated documents were manually examined to
reduce ambiguous gene symbols that may represent
genes, diseases, cell lines, experiment techniques or other
terms simultaneously. If any ambiguous terms were fre-
quently matched in the text and do not mean genes, these
gene symbols would be regarded as stop words and
excluded from the gene name dictionary. We then anno-
tated gene names in the literature again with the improved
dictionary. In other words, the process can be executed
after every update of the literature corpus so that the dic-
tionary could be more specific and precise to the research
domain. The approach mainly followed our pervious
work [28]. Since term ambiguity may occur between gene
symbols (for example, p38 may represent MAPK1 or
MAPK14), the NCBI Entrez gene IDs of the official gene
symbols was assigned to the symbols or their aliases, if
any, for the following association discovery.
In the disease name lexicon, if a term contains comma
such as 'Tumors, Breast', all words of this term were indi-
vidually queried against documents and the word
sequence was ignored. If these words can be matched in a
document, we assumed the document was identified by
the term. Other terms without comma were directly que-
ried against text.
The putative TCM effect list was generated by rule-based
approach mentioned below. Synonyms such as 'anti-
tumor' and 'anti-tumour' were manually grouped before
annotation.
Association discovery
Annotated literature corpus was then used to find various
associations including (TCM, gene), (TCM, disease),
(TCM, gene, disease), (TCM, ingredient), (TCM, effect)
and (gene, ingredient). The concept to discover associa-
tions was based on hypothesis testing and collocation, an
expression consisting of two or more words that tend to
occur together [29]. The statistical methods based on co-
occurrences can be very fast and useful for getting precise
information [30]. One can observe the co-occurrence of
these entities in abstracts and calculate how improbable it
is to observe a certain level of co-occurrences by chance.
The null hypothesis (H0) is that the co-occurrences
between TCM and entities are by chance, and so the prob-
ability of the terms appearing concurrently is given by:
P(term1term2) = P(term1)P(term2). Since a term may
include multiple synonyms, the occurrence probability of
the term has to be represented by all its synonyms to
reflect the real weight of this term. For example, if gene A
has three synonyms, gene A1, gene A2 and itself and each
of them occurs one, two and three times in text, respec-
tively, then the total occurrence number of gene A is six in
fact. The t test that looks at the mean and variance of a
sample of measurements was then used to discover collo-
cations. The t value was calculated with the following for-
mula:   where   is the observed probability, μ is
the expected probability, s2 is the sample variance and N
is the sample size, the total number of tokens in the cor-
pus. If the t value is larger than 2.576, 2.326, 1.960 or
1.645, we can reject the null hypothesis with 99.5%, 99%,
97.5% or 95% confidence, respectively. In other words,
associations discovered by chance would have low statis-
tical values and not be shown or rank low in the results
based on the threshold set by users.
Rule-based information extraction
To extract the relations between effecters and effects from
literature, sentences were part-of-speech (POS)-tagged by
Genia Tagger [31] and noun-phrase (NP) chunks were
identified by NPchunker [32]. The effecter and effect rela-
tions were extracted by matching preprocessed sentences
with manually designed four rule patterns for high preci-
sion. For example, "[The/DT anti-androgenic/JJ activity/NN]
of/IN [the/DT ethanol/NN extract/NN] of/IN [the/DT fruit-
ing/VBG body/NN] of/IN [Ganoderma/NN lucidum/NN]
has/VBZ been/VBN previously/RB reported/VBN./." is a POS-
tagged and NP chunked sentence where each square
bracket represents a NP.
Rule for effect extracts terms POS-tagged as adjectives and
followed by effect-related keywords (for example, 'anti-
tumor activity'). The corresponding pattern is as follows:
[? (effect term/JJ) (selected keyword)/NN] where the
selected keywords for effect identification include 'effect',
'activity', 'potential', 'property' and 'function', parenthesis
represents priority, | denotes 'or' and ? denotes optional
argument. The extracted terms without biological signifi-
cances such as 'important' or 'great' were manually
excluded.
Rule 1 extracts effect and effecter NP chunks connected by
of. The effecter names could be composed of multiple
chunks. The corresponding pattern is as follows: [? (effect)
(keyword)/NN] of/IN [effecter 1] (((of | from)/IN
[effecter 2] of/IN [effecter 3])|nil) where effecters 1, 2 and
t
x
s
N
=
−μ
2 xBMC Complementary and Alternative Medicine 2008, 8:58 http://www.biomedcentral.com/1472-6882/8/58
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3 represent the first, second and third NPs in the effecter
name, respectively. For example, the above-mentioned
example sentence can be matched by this rule and the
effecter, 'the ethanol extract of the fruiting body of Ganoderma
lucidum' and effect, 'anti-androgenic' are able to be
extracted.
Rule 2.1 extracts effecter and effect NP chunks connected
by active verbs. The effecter names are composed of two
NP chunks connected by of or in. The following is the cor-
responding pattern: [effecter 2] (of | in)/IN [effecter 1]
(modal/MD|nil) verb/VB [? (effect) (keyword)/NN]. For
instance, a sentence matched by this rule can be 'the
polysaccharides fraction of G. lucidum exhibited significant
anti-tumor effect' and effecter, 'the polysaccharides fraction of
G. lucidum', and effect, 'anti-tumor', can be extracted.
Rule 2.2 is similar to Rule 2.1, but extracts one or more
effecters connected by and. The following is the corre-
sponding pattern: [1st effecter] (((n-2 effecters) and/CC
[nth  effecter])|nil) (modal/MD|nil) verb/VB [? (effect)
(keyword)/NN] where n is greater than or equal to two if
there are multiple effecters mentioned. The sentence, for
example, 'Lingzhi and San-Miao-San capsules might exert a
beneficial immunomodulatory effect' is able to be matched by
this rule and effecters, 'Lingzhi and San-Miao-San capsules',
and effect, 'immunomodulatory', can be extracted.
Rule 3.1 extracts effecter and effect NP chunks connected
by past participle verbs that are frequently observed in
English for describing research discoveries. The corre-
sponding pattern is as follows: [effecter 2] (of | in)/IN
[effecter 1] (was | were)/VBD keyword/VBN to/TO verb/
VB [? (effect) (keyword)/NN] where the keywords for VBN
include 'found', 'shown', 'demonstrated', 'known', 'con-
cluded', 'reported', 'proved', 'seen', 'suggested' and
'observed'. For example, this rule can match the sentence,
'hot water extract of the mushroom Ganoderma lucidum was
found to exhibit antioxidative effect' and 'hot water extract of
the mushroom Ganoderma lucidum' and 'antioxidative' can be
extracted as effecter and effect, respectively.
Rule 3.2 is similar to Rule 3.1, but extracts one or more
effecters connected by and. The corresponding pattern is
as follows: [1st  effecter] (((n-2 effecters) and/CC [nth
effecter])|nil) (was | were)/VBD keyword/VBN to/TO
verb/VB [? (effect) (keyword)/NN]. For instance, effecter,
'APBP', and effect, 'antiviral', are able to be extracted from
the sentence, 'APBP was shown to have potent antiviral activ-
ity'.
Rule 4 extracts effecter and effect NP chunks connected by
appositives modifying effecters, and verb phrases. The fol-
lowing is the corresponding pattern: [effecter],/, apposi-
tive,/, (modal/MD|nil) verb-phrase [(effect) (keyword)/
NN]. For example, the sentence, 'LZ-8, a new and recently
discovered immunomodulator from Ganoderma lucidum, has
been shown to have immunosuppressive activity' can be
matched and effecter, 'LZ-8', and effect, 'immunosuppres-
sive', are able to be extracted, respectively.
The candidate relations having following conditions were
excluded: (i) the extracted effects can't be identified in the
effect set; (ii) the effecters are non-specific terms such as
compound and sample; (iii) the start words of the effect
NP chunks are 'no'.
Transitive association
We inferred transitive associations about TCMs according
to Swanson's ABC model where if A and B are related, and
B and C are related, then A and C might be indirectly
related [33]. For TCM and gene association inference, we
assumed that gene (A) activities may be regulated by vari-
ous ingredients (B) isolated from the TCMs (C) and esti-
mated the generated relationships by the formula:
, where n is the number of ingredients
involved,   denotes  the  t value for gene (A) and ingre-
dient (Bi) and   denotes the t value for ingredient (Bi)
and TCM (C). As the work we referred, if the relationships
between A and B, and B and C are more significant (higher
tAB and tBC), the inferred associations between A and C
could be more reliable (higher score calculated). Similar
concept could be applied to correlate TCMs (A) with dis-
eases (C) via known disease candidate genes (B). If the
relationships between TCMs and these genes are more sig-
nificant, the associations between TCMs and diseases con-
tributed by these genes could be more promising.
Results
Utility
The database can be accessed by TCM Latin names, gene
symbols, gene-related keywords, disease names and TCM
effects to find various associations and integrated infor-
mation. TCM, gene and disease associations could be pre-
sented in network graphs. In TCMGeneDIT, TCM tree
browser is also available for users unfamiliar with TCM
Latin names. The main search interface is composed of
three sections including (i) TCMs and Genes, (ii) Dis-
eases, (iii) TCM effects, and different options. Figure 3
shows one of the major features of TCMGeneDIT, the
associations between TCM and genes, and visual represen-
tations for (TCM, gene) and (TCM, gene, disease).
In order to retrieve association information regarding
Ganoderma lucidum, for example, users can select 'TCM
tt AB B C
i
n
ii ⋅
= ∑
1
t ABi
tBC iBMC Complementary and Alternative Medicine 2008, 8:58 http://www.biomedcentral.com/1472-6882/8/58
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The TCM and gene associations and visual information representations Figure 3
The TCM and gene associations and visual information representations. (a) The Ganoderma lucidum and gene associ-
ations from text mining. Detailed information about TCM and genes could be accessed by following the links themselves. Liter-
ature evidences supporting the associations are available through following the links indicating the number of paper. 
Confidence thresholds are able to be selected. Users with domain knowledge can recommend the associations they think are 
correct. Moreover, TCM and gene associations could be discovered by transitive inference. (b) TCM and gene association 
graph. TCM and genes are represented by green and yellow nodes, respectively. The edges between them are colored accord-
ing to t values (please see the text). The numbers on the edges mean how many literatures may support the associations. (c) 
TCM, gene and disease association graph. Red nodes mean diseases.
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Herb' search type, input Ganoderma lucidum as the search
term and then click on the "Search" button. If the search
is matched, the TCM information, including three links
for TCM-Gene, TCM-Disease and TCM-Gene-Disease,
ingredients collected from other databases and mined
from literature, potential effects from text mining, and
putative relations between effecters and effects extracted
from the text will be shown. All association information is
presented with t values in different colors, red (>2.576),
green (>2.326) and blue (>1.960). Users can then follow
the links for evidences in sentences from the literature,
highlighted keywords, identified genes, journals and pub-
lication years. To examine the relationships between Gan-
oderma lucidum and genes, users can click on the TCM-
Genes link and the returned web page will contain associ-
ations ranked by the t values and vote number. The vote
features were presented for users with domain knowledge
to recommend correct associations. Users are able to
examine associations with preferred confidence levels.
The default value is 97.5%. Evidence extracted from the
literature can be accessed by following the link showing
the number of paper. Users can then follow the links of
gene names for general information and associations
between specific genes and different TCMs. Furthermore,
users are able to find which genes and diseases may be
related to Ganoderma lucidum via the link TCM-Gene-Dis-
ease. The default results are associations purely generated
from collocation analysis. The links of diseases are for
users to examine disease descriptions from MeSH and
which TCMs may be related to the disease. Additional
TCM, gene and disease association information could be
accessed by transitive inference, as the relationships
between genes and diseases collected from PharmGKB are
integrated to the text mining results of TCMs and genes.
To search for association information using gene names,
users can select 'Gene Symbol' search type, for example,
input 'TNF-alpha' as search term and select the gene of
interest in the returned page. If users follow the link of
TNF gene ID, a variety of gene information are shown,
including gene description, function, two links for TCM-
Gene and TCM-Gene-Disease, Gene Ontology annota-
tion, involved biological pathways and interacting protein
partners. For those who would like to find the associa-
tions of specific disease, such as Alzheimer's disease, with
TCMs or both the TCMs and genes, can simply select the
disease name in the main search interface. Disease
description and three links for TCM-Disease, TCM-Gene-
Disease and TCM-Gene-Disease (transitive) will be pre-
sented. The transitive disease, TCM and gene associations
are inferred via common TCMs and preferred confidence
levels for disease-TCM and TCM-gene associations can
also be set. The associations between TCMs and particular
effects can be accessed in the third section of the main
search interface. For example, Ganoderma lucidum may be
most associated with 'antitumor' effect.
Inference of the relationships between TCMs and genes 
through TCM ingredients
In addition to providing associations between TCMs and
genes by their co-occurrences, TCMGeneDIT could infer
their transitive relationships through the shared interme-
diates, ingredients. For example, in the initial result page
of Ganoderma lucidum and gene associations, users can fol-
low the link 'by transitive inference' and select one or
more ingredients of interests to perform relationship
inference. Then, our system would try to find putative
associations between TCMs and genes according to the
sorted scores calculated by the above-mentioned formula:
. In this example, TNF (Tumor Necrosis Fac-
tor) is suggested to be the gene highly associated with
Ganoderma lucidum if users select polysaccharide and trit-
erpene, the main ingredients of the TCM, to infer the rela-
tionships. Potential transitive associations with high
scores but not explicitly found in the literature may be
regarded as candidates for hypotheses generation.
Discussion
To evaluate the association information discovered by the
collocation analysis, we randomly selected 50 TCMs
related to genes and/or diseases, and used precision meas-
urement to estimate the performances. The mined results
manually confirmed as correctness were considered true
positives. Precision is defined as follows:
, where TP and FP are the numbers of
tt AB B C
i
n
ii ⋅
= ∑
1
precision = +
TP
TP FP
Table 1: Evaluation of the associations between TCMs and various entities from collocation analysis
(TCM, Gene) (TCM, Disease) (TCM, Gene, Disease) (TCM, Effect)
Precision (%) 92.8 86.0 87.0 96.5
Number of associations 666 642 131 570
Minimum confidence (%) 95 95 95 97.5
Number of TCMs contributed to the associations 48 47 23 44BMC Complementary and Alternative Medicine 2008, 8:58 http://www.biomedcentral.com/1472-6882/8/58
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true positives and false positives, respectively. Table 1
shows the evaluation results for various associations. The
precisions of 666 (TCM, gene), 642 (TCM, disease), and
131 (TCM, gene, disease) associations with 95% confi-
dence level are 92.8%, 86.0% and 87.0%, respectively. In
addition, the (TCM, effect) associations and TCM effect
relations extracted from literature were also evaluated.
There are 570 (TCM, effect) associations at 97.5% confi-
dence level with a precision of 96.5%. To evaluate the pre-
cision of the extracted relations between effecter and
effect, 20 TCM entries were randomly selected in the test
set and the precision of the 1185 relations is 91.2%. The
analysis of errors in association discovery showed that
false positives were primarily caused by ambiguous gene
symbols that could not be excluded in the annotation
phase (for example, AP-1 may represent JUN gene or
Angelica sinensis polysaccharide 1) and general MeSH dis-
ease entry term such as 'Toxicity, Drug' or 'Poisoning'. The
analysis of errors in relation extraction indicated that the
most principal sources of errors came from incomplete,
incorrect or non-specific enough effecter NPs.
TCMGeneDIT could be used to understand the possible
therapeutic mechanisms of TCMs via gene regulations.
Take  Ganoderma lucidum and anti-tumor for example.
From the database TCM search, the mining results indi-
cated Ganoderma lucidum may be highly associated with
anti-tumor effect (t-value>6.1). In addition, the TCM and
gene association information showed IFNG (interferon,
gamma), IL1B (interleukin 1, beta), TNF, NFKB1 (nuclear
factor of kappa light polypeptide gene enhancer in B-cells
1) and IL2 (interleukin 2) genes were significantly related
to Ganoderma lucidum (t-values >3.3). Furthermore, the
functional classifications of Gene Ontology available in
the gene search results revealed that most these genes are
involved in apoptosis (80%) and cell proliferation (60%),
in which both are correlated with tumorigenesis. The find-
ings suggested Ganoderma lucidum may have therapeutic
effects on cancers through the regulations of apoptosis
and cell proliferation. Recent studies have shown that
Ganoderma lucidum can induce apoptosis of prostate can-
cer cells (PC-3) via decreasing the expression of NFKB1-
regulated genes [34] and Ganoderma lucidum is able to
inhibit TNF-induced proliferation of human breast cancer
cells through modulation of the NFKB1 signaling [35].
On the other hand, several active ingredients such as
polysaccharides, triterpenes, ganoderic acids highly asso-
ciated with Ganoderma lucidum (t-values>5) may contrib-
ute to the putative mechanisms. As our expected,
Ganoderma lucidum polysaccharides have been shown that
can modulate the concentrations of IL2, IFNG, TNF, and
NFKB1 in patients with advanced colorectal cancer [36],
and ganoderic acid Me can inhibit tumor growth and lung
metastasis through increasing the expressions of IL2,
IFNG and NFKB1 [37]. These results indicated that TCM-
GeneDIT could suggest the possible therapeutic mecha-
nisms involved by TCMs, genes and TCM ingredients, and
provide a one-stop site for TCM and modern biomedical
researchers.
TCMGeneDIT may also be useful to determine which
components of the prescription composite formulae will
produce a synergistic effect or an antagonistic action. We
applied TCMGeneDIT to 3 immune-related prescriptions,
Dang Guei Bu Syue Tang composed of Astragalus mem-
branaceus (Huang Ci) and Angelica sinensis (Dang Guei),
Sheng Mai San composed of Panax ginseng (Ren Shen Ye),
Ophiopogon japonicus (Cun Dong) and Schisandra chinensis
(Bei Wu Wei), and Sih Jyun Zih Tang composed of Codo-
nopsis pilosula (Dang Shen), Atractylodes macrocephala (Bai
Jhu), Poria cocos (Bai Fu Ling) and Radix Glycyrrhizae (Wu
Jhu Yu). From the database TCM effect search, we could
find all herbs to be immune-related such as immunopo-
tentiating, immunological, immunomodulatory or anti-
inflammatory. In the case of Dang Guei Bu Syue Tang,
both herbs had high t-values, 3.303 and 2.221, respec-
tively, for antitumor effect and were both significantly
associated with IL-2 and TNF. Both IL-2, a secreted
cytokine important for the proliferation of T and B lym-
phocytes, and TNF, a multifunctional proinflammatory
cytokine secreted by macrophages, are also known to be
involved in cytokine-cytokine receptor interaction, which
can be found from our database gene search. Thus, Astra-
galus membranaceus and Angelica sinensis may synergisti-
cally promote the immune effect of Dang Guei Bu Syue
Tang. On the other hand, in Sheng Mai San, Panax ginseng
is highly related to immune or immunomodulatory
effects but Ophiopogon japonicus and Schisandra chinensis
are only slightly immune-related (confidence < 95%).
Both Panax ginseng and Ophiopogon japonicus are associ-
ated with TNF, while Panax ginseng and Schisandra chinen-
sis  are both related to IL-6 (interleukin 6), IL-4
(interleukin 4) and IL-10 (interleukin 10). In addition to
cytokine-cytokine receptor interaction, IL-6, IL-4 and IL-
10 are all involved in the regulation of the Jak-STAT sign-
aling pathway and cytokines and inflammatory responses,
which are supported by the KEGG and CGAP -integrated
gene search results. Therefore, Panax ginseng may very pos-
sibly be the major component of Sheng Mai San, in which
the immune function is produced by synergistic herb
pairs. Although more investigation is required to find the
underlying therapeutic mechanisms of the various pre-
scriptions, TCMGeneDIT would certainly facilitate the
understanding of the roles played by herb components in
producing prescription effects.BMC Complementary and Alternative Medicine 2008, 8:58 http://www.biomedcentral.com/1472-6882/8/58
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Comparison between TCMGeneDIT and TCM-ID
The TCMGeneDIT differs from the TCM-ID in several
ways. First, TCMGeneDIT provides association informa-
tion about TCMs mined and extracted from a large
amount of literature based on collocation analysis, as it
joins TCMs with biomedical studies and modern life sci-
ences, especially genomics and proteomics. In addition,
the transitive relationships between TCMs and genes and/
or diseases could be inferred through TCM ingredients
and information integration. Furthermore, integrated pro-
tein-protein interaction and biological pathway could
help to suggest the underlying therapeutic mechanisms of
TCMs and genes.
Future developments
Future research includes expanding database contents by
adding information on prescription composite formulae,
TCM ingredient structures, as well as integrating the rela-
tionships among Western drugs, genes and diseases, and
creating TCM Ontology to describe TCMs and their prop-
erties and attributes. We are also planning on developing
new rules and extend existing patterns for extracting more
relations about TCMs. Furthermore, we intend to offer
query functions for network visualization, thus enhancing
the study of therapeutic pathways involving TCMs and
genes.
Conclusion
We developed a unique database, TCMGeneDIT, which
provides association information about TCMs, genes and
diseases using scientific text mining, integrating TCMs
with biomedical studies. It will not only help facilitate the
understanding of therapeutic mechanisms involving TCM
and gene interactions, but also be constructive to modern
clinical research.
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